These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports. Karadağ F; Tan D; Unal F Turk Psikiyatri Derg; 2011; 22(4):269-72. PubMed ID: 22143953 [TBL] [Abstract][Full Text] [Related]
6. Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report. Ballester-Gracia I; Pérez-Almarcha M; Galvez-Llompart A; Hernandez-Viadel M BMC Pharmacol Toxicol; 2019 Aug; 20(1):52. PubMed ID: 31462311 [TBL] [Abstract][Full Text] [Related]
7. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH]. Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Battini V; Cirnigliaro G; Giacovelli L; Boscacci M; Massara Manzo S; Mosini G; Guarnieri G; Gringeri M; Benatti B; Clementi E; Dell'Osso B; Carnovale C Expert Rev Clin Pharmacol; 2023 May; 16(5):453-465. PubMed ID: 37147189 [TBL] [Abstract][Full Text] [Related]
9. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays. Melanson SE; Lee-Lewandrowski E; Griggs DA; Long WH; Flood JG Arch Pathol Lab Med; 2006 Dec; 130(12):1834-8. PubMed ID: 17149959 [TBL] [Abstract][Full Text] [Related]
10. The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Calabrese JR; Sanchez R; Jin N; Amatniek J; Cox K; Johnson B; Perry PP; Hertel P; Such P; McQuade RD; Nyilas M; Carson WH J Affect Disord; 2018 Dec; 241():425-432. PubMed ID: 30145513 [TBL] [Abstract][Full Text] [Related]
11. Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. Calabrese JR; Sanchez R; Jin N; Amatniek J; Cox K; Johnson B; Perry P; Hertel P; Such P; McQuade RD; Nyilas M; Carson WH J Affect Disord; 2018 Feb; 227():649-656. PubMed ID: 29174738 [TBL] [Abstract][Full Text] [Related]
12. Popular dietary supplement causes false-positive drug screen for amphetamines. Pavletic AJ; Pao M Psychosomatics; 2014; 55(2):206-7. PubMed ID: 23932535 [No Abstract] [Full Text] [Related]
13. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348 [TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of an improved method for screening of amphetamines. Shindelman J; Mahal J; Hemphill G; Pizzo P; Coty WA J Anal Toxicol; 1999 Oct; 23(6):506-10. PubMed ID: 10517558 [TBL] [Abstract][Full Text] [Related]
15. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate. Kaplan YC; Erol A; Karadaş B Ther Drug Monit; 2012 Oct; 34(5):493-5. PubMed ID: 22972534 [TBL] [Abstract][Full Text] [Related]
16. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay. Casey ER; Scott MG; Tang S; Mullins ME J Med Toxicol; 2011 Jun; 7(2):105-8. PubMed ID: 21191682 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. San L; Estrada G; Oudovenko N; Vieta E BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877 [TBL] [Abstract][Full Text] [Related]